Table 2 Laboratory indexes of the study participants
From: Association between SUMF1 polymorphisms and COVID-19 severity
Parameters | Casesa (N = 285) | Controlsb (N = 141) | Z | Pc values |
|---|---|---|---|---|
WBC (×109/L) | 6.048 ± 1.898 | 6.683 ± 2.068 | -3.056 | 0.002 |
NE (×109/L) | 3.620 ± 1.429 | 4.602 ± 1.889 | -2.021 | 0.043 |
LY (×109/L) | 1.405 ± 0.683 | 1.851 ± 0.538 | -3.121 | 0.002 |
MONO (×109/L) | 0.339 ± 0.156 | 0.347 ± 0.126 | -0.853 | 0.394 |
EOS (×109/L) | 0.046 ± 0.060 | 0.065 ± 0.058 | -1.264 | 0.206 |
BAS (×109/L) | 0.017 ± 0.017 | 0.025 ± 0.014 | -3.315 | 0.001 |
RBC (×1012/L) | 4.398 ± 0.974 | 4.811 ± 0.606 | -2.989 | 0.003 |
HB (g/L) | 131.375 ± 29.748 | 144.500 ± 18.368 | -3.261 | 0.001 |
PLT (×109/L) | 214.875 ± 83.806 | 247.518 ± 53.034 | -0.775 | 0.438 |
ALB (g/L) | 44.461 ± 5.609 | 49.261 ± 3.149 | -6.897 | < 0.001 |
ALT (U/L) | 35.311 ± 49.912 | 29.313 ± 27.707 | -1.45 | 0.147 |
AST (U/L) | 32.732 ± 31.802 | 21.171 ± 6.054 | -1.153 | 0.249 |
Scr (µmol/L) | 66.829 ± 12.887 | 68.875 ± 12.651 | -0.121 | 0.904 |
BUN (mmol/L) | 4.820 ± 1.208 | 4.798 ± 1.246 | -1.283 | 0.199 |
TBIL (µmol/L) | 10.343 ± 6.128 | 11.614 ± 5.188 | -2.026 | 0.043 |
DBIL (µmol/L) | 3.334 ± 1.665 | 4.316 ± 2.259 | -4.163 | < 0.001 |
IBIL (µmol/L) | 7.009 ± 4.798 | 7.298 ± 3.102 | -0.983 | 0.326 |
D-dimer (µg/L) | 330.688 ± 299.289 | 256.964 ± 300.139 | -0.906 | 0.365 |
PT (s) | 11.405 ± 2.186 | 11.421 ± 0.643 | -0.644 | 0.520 |
INR | 2.941 ± 14.431 | 0.993 ± 0.058 | -0.41 | 0.681 |
PTA (%) | 113.520 ± 8.446 | 104.079 ± 9.143 | -0.221 | 0.825 |
APTT (s) | 27.423 ± 4.373 | 27.082 ± 2.309 | -0.474 | 0.635 |
FIB (g/L) | 3.102 ± 0.859 | 2.425 ± 0.578 | -4.577 | < 0.001 |
TT (s) | 16.763 ± 1.282 | 18.416 ± 5.985 | -4.948 | < 0.001 |
ESR (mm/h) | 25.643 ± 26.681 | 11.821 ± 8.550 | -2.919 | 0.004 |
CRP (mg/L) | 9.672 ± 18.336 | 2.147 ± 12.127 | -3.654 | < 0.001 |
SAA (mg/L) | 45.182 ± 86.163 | 12.886 ± 58.340 | -5.634 | < 0.001 |